H&R CHEMPHARM (UK) LIMITED

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers

• Turnover

  +8.5%

  £28,252,727 → £30,646,297

• Cash

  +47.6%

  £3,174,885 → £4,685,565

• Net assets

  +2.1%

  £6,810,839 → £6,950,992

• Employees

  +4%

  50 → 52

• Operating profit

  +40.2%

  £4,003,680 → £5,613,425

• Profit before tax

  +40.9%

  £3,867,764 → £5,450,543

• Wages

  +12%

  £2,349,763 → £2,630,603

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

1. H&R CHEMPHARM (UK) LIMITED 2006-06-27 → present
2. H&R CHEM PHARM (UK) LIMITED 2005-12-02 → 2006-06-27
3. H&R CHEM PHARM LIMITED 2005-12-01 → 2005-12-02

Accounting basis

FRS 102

Reporting scope

Standalone (parent only)

Auditor

Grant Thornton UK LLP

Audit opinion

Unqualified (clean)

Going concern

Affirmed

“The directors have prepared monthly cash flow forecasts for 2025 and then yearly forecasts from 2026 until 2028 and stress tested these for reasonably possible alternative scenarios as well as considering severe or worst case positions. The company sells into various markets and the directors have considered potential impacts from a sustained loss in demand from these markets. Visibility of projects within our core cables business supports the underlying profitability of our business. In addition continued raw material cost increases have been considered and the ability to maintain margins evaluated in light of these. These scenarios show the business will remain profitable and the company will have sufficient liquidity to meet its liabilities as they fall due. Based on the above, the directors believe that it remains appropriate to prepare the financial statements on a going concern basis.”

Significant events

• “Since the invasion of Ukraine by Russian troops in 2022 challenges in raw material pricing and availability, higher energy costs, high interest rates and the cost of living crisis have impacted the business.”
• “A number of large investments have been identified for 2025 through 2026, these will support our move towards sustainability, provide support against supply chain challenges and enable further growth”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

3

last 12 months

Capital events

0

last 24 months

Officers appointed

0

last 12 months

Officers resigned

0

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.